2023 American Academy of Neurology Abstract Website

Mackenzie A. Michell-Robinson¹, Kristin EN Watt², Vladimir Grouza³, Julia Macintosh¹, Maxime Pinard⁴, Marius Tuznik³, Xiaoru Chen¹, Lama Darbelli¹, Chia-Lun Wu¹, Stefanie Perrier¹, Daryan Chitsaz⁵, Nonthue A Uccelli⁵, Hanwen Liu³, Timothy Cox⁶, Christoph W Mueller⁷, Timothy E Kennedy⁵, Benoit Coulombe⁴, David Rudko³, Paul A Trainor², Geneviève Bernard¹
¹Research Institute of the McGill University Health Centre, ²Stowers Institute for Medical Research, ³McConnell Brain Imaging Centre, ⁴Montreal Clinical Research Institute, ⁵Montreal Neurological Institute, ⁶School of Medicine, University of Missouri - Kansas City, ⁷European Molecular Biology Laboratory

Objective:

To develop the first model of RNA Polymerase III (Pol III)-Related Hypomyelinating Leukodystrophy (POLR3-HLD) based on a POLR3B mutation.

Background:

POLR3-HLD is a devastating neurological disease characterized by severe diffuse hypomyelination and progressive functional decline leading to early death. It is caused by biallelic pathogenic variants in genes encoding Pol III subunits. Patients are most commonly affected by mutations in POLR3A or POLR3B, but there are currently no disease models based on POLR3B. Furthermore, existing models of the disease based on POLR3A mutation fail to replicate the hypomyelination severity commonly observed in patients. We hypothesize that mutations in Pol III subunits such as POLR3B reduce enzyme function during a critical developmental period causing defective myelinogenesis and hypomyelination.

Design/Methods:

We characterized the impact of a POLR3B mutant lacking exon 10 (POLR3BΔ10) on Pol III complex assembly, nuclear import, and protein expression in human cells. We developed an inducible/conditional animal model using the cre/lox system to express the orthologous mutation in a Pdgfrα-dependent manner during postnatal development in mice. The animal model was characterized using a variety of techniques including tissue biochemistry, histology, and advanced imaging (microCT, ex vivo MRI).

Results:

POLR3BΔ10 expression was shown to cause a severe Pol III assembly defect accompanied by reduced expression and nuclear import of the mutant protein in human cells. Inducing Pdgfrα-dependent expression of orthologous Polr3b∆10 during postnatal development in mice causes severe hypomyelination, craniofacial defects, and hypodontia. The hypomyelination phenotype was caused by proliferation and maturation defects in oligodendrocyte-lineage cells carrying homozygous Polr3b∆10, which preceded hypomyelination and led to non-apoptotic cell loss from the brain parenchyma.

Conclusions:

We describe the first severe model of POLR3-HLD and the first working disease model based on mutation of Polr3b. This work advances our understanding of POLR3-HLD and implicates defective proliferation and differentiation of oligodendrocyte-lineage cells as key features of POLR3-HLD pathogenesis.